P3 Trial was Conducted►ONLY w/ N.American Patients!~So It May Fail Again Like 2009 If They Do Other Countries
UPDATE -Acadia Antipsychotic Drug
Tue Nov 27, 2012
Nov 27 (Reuters) - The Acadia drug in 2009 failed to meet the goals of a previous Phase III study due to what the company said was an unusually large placebo effect. Much of that effect came from patients in Eastern Europe and India, where they were exposed during the trial to much better healthcare standards than is typical for such patients in those countries, possibly contributing to the placebo effect, Hacksell explained.
The latest trial was conducted only with North American patients.